These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein. Ji S; Na L; Ren H; Wang Y; Wang X J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377 [TBL] [Abstract][Full Text] [Related]
6. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction. Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303 [TBL] [Abstract][Full Text] [Related]
7. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid. Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692 [TBL] [Abstract][Full Text] [Related]
8. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794 [TBL] [Abstract][Full Text] [Related]
9. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction. Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207 [TBL] [Abstract][Full Text] [Related]
10. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation. Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880 [TBL] [Abstract][Full Text] [Related]
11. The SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis. Guo H; Yang W; Li H; Yang J; Huang Y; Tang Y; Wang S; Ni F; Yang W; Yu X-F; Wei W mBio; 2024 Jul; 15(7):e0136324. PubMed ID: 38888311 [TBL] [Abstract][Full Text] [Related]
12. Host and viral determinants of Mx2 antiretroviral activity. Busnadiego I; Kane M; Rihn SJ; Preugschas HF; Hughes J; Blanco-Melo D; Strouvelle VP; Zang TM; Willett BJ; Boutell C; Bieniasz PD; Wilson SJ J Virol; 2014 Jul; 88(14):7738-52. PubMed ID: 24760893 [TBL] [Abstract][Full Text] [Related]
13. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6. Xie L; Chen L; Zhong C; Yu T; Ju Z; Wang M; Xiong H; Zeng Y; Wang J; Hu H; Hou W; Feng Y Retrovirology; 2020 Jun; 17(1):16. PubMed ID: 32600399 [TBL] [Abstract][Full Text] [Related]
14. MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylation. Betancor G; Jimenez-Guardeño JM; Lynham S; Antrobus R; Khan H; Sobala A; Dicks MDJ; Malim MH Nat Microbiol; 2021 Aug; 6(8):1031-1042. PubMed ID: 34282309 [TBL] [Abstract][Full Text] [Related]
16. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177 [TBL] [Abstract][Full Text] [Related]
17. Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal. Schulte B; Buffone C; Opp S; Di Nunzio F; De Souza Aranha Vieira DA; Brandariz-Nuñez A; Diaz-Griffero F J Virol; 2015 Aug; 89(16):8599-610. PubMed ID: 26063425 [TBL] [Abstract][Full Text] [Related]
18. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions. Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975 [TBL] [Abstract][Full Text] [Related]